Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jove

Showing results (301-310 of 517) with videos related to

Pageof 52
Sort By:
Epidemiology (Cambridge, Mass.)|October 1, 2013
Relative risks from case-population dataNicholas Moore, Sinem Ezgi Gulmez, Patrick Blin, et al.
Inorganic Chemistry|January 30, 2007
Unusual polybrominated polypyrazolylborates and their copper(I) complexes: synthesis, characterization, and catalytic activityGlen P A Yap, Fernando Jove, Juan Urbano, et al.
Molecular Cancer Therapeutics|February 27, 2004
AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1Jason Savell, Yihong Ma, Kristin S Morrow, et al.
Cancer Research|December 18, 2003
Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2Subhra Mohapatra, Baoky Chu, Sheng Wei, et al.
Science (New York, N.Y.)|July 7, 1995
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoproteinC L Yu, D J Meyer, G S Campbell, et al.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Multiple Myeloma: New Insights and Therapeutic ApproachesKenneth C. Anderson, Robert A. Kyle, William S. Dalton, et al.
Molecular Cancer Therapeutics|March 21, 2006
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 proteinAnupama Kotha, Madhavi Sekharam, Lucia Cilenti, et al.
Cellular Immunology|November 12, 2002
Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophilsP K Epling-Burnette, Roy Garcia, Fanqi Bai, et al.
The Journal of Biological Chemistry|May 24, 2000
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activityY Zhang, J Turkson, C Carter-Su, et al.
Pageof 52

Showing results (301-310 of 517) with videos related to

Sort By:
Pageof 52
Epidemiology (Cambridge, Mass.)|October 1, 2013
Relative risks from case-population dataNicholas Moore, Sinem Ezgi Gulmez, Patrick Blin, et al.
Inorganic Chemistry|January 30, 2007
Unusual polybrominated polypyrazolylborates and their copper(I) complexes: synthesis, characterization, and catalytic activityGlen P A Yap, Fernando Jove, Juan Urbano, et al.
Molecular Cancer Therapeutics|February 27, 2004
AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1Jason Savell, Yihong Ma, Kristin S Morrow, et al.
Cancer Research|December 18, 2003
Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2Subhra Mohapatra, Baoky Chu, Sheng Wei, et al.
Science (New York, N.Y.)|July 7, 1995
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoproteinC L Yu, D J Meyer, G S Campbell, et al.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Multiple Myeloma: New Insights and Therapeutic ApproachesKenneth C. Anderson, Robert A. Kyle, William S. Dalton, et al.
Molecular Cancer Therapeutics|March 21, 2006
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 proteinAnupama Kotha, Madhavi Sekharam, Lucia Cilenti, et al.
Cellular Immunology|November 12, 2002
Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophilsP K Epling-Burnette, Roy Garcia, Fanqi Bai, et al.
The Journal of Biological Chemistry|May 24, 2000
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activityY Zhang, J Turkson, C Carter-Su, et al.
Pageof 52